NEU

3.50%

$14.05 neuren pharmaceuticals limited

Good to remember some of the older chit chat on valuations and...

First 205 Last

Share
Profile

Follow
perthpest

564 Posts.

53

18/03/23

10:56

Post #: 66836931
Share

Originally posted by Taureanbull: ↑

Perthpest,

Good post. Remember what Shire Pharmaceuticals did with Orphan Drugs a few years back.

If we were Nasdaq Listed we wouldn’t be wallowing down here at $2.22. Your valuation comes out at $132 per share. Sounds crazy but we have all seen Nasdaq companies have moves like this with successful trials.

And that’s not including our 5 other indications. This isn’t like the old days when a biotech tried to cure diseases with random small molecule drugs they found in venomous animals or rainforests etc. The knowledgeable scientists progressing both our drugs have a very good idea what to expect. As Jon Pilcher just said the pre-clinical studies for 2591 have extraordinary results.

NEU is only 12 months from Ph2 results for 4 more indications. If they were to prove successful a certain value would have to be attributed to the possible success of even more indications. Is NEU currently doing pre-clinical work in more diseases. Are any any of the many companies that NEU are in discussions with, offering partnerships and money to pursue the big issues, Dementia,Autism,Parkinsons and Huntington’s ??!???

Now that the ASX market has had a taste of Nasdaq style success with Afterpay , Atalassian and others, punters will be keen for more high tech global winners. Post Ph3 results NEU will be front page of Financial Press.

I really do think many investors have a bad relationship ship with money, they are afraid of success and don’t believe they deserve to win big time. They don’t date to dream big. To my mind that’s why most people don’t get really wealthy. Most people don’t ever achieve wealth because they can’t overcome the mindset of hard work and frugality., This work is awash with money. It’s never been easier to earn immense wealth.

All an investor has to do , is trawl the stock market and find tomorrow’s winners. They are in by people with big dreams, courage and tenacity. NEU is one of those stories. 30 years of science and hard work.

The number companies that will be big winners is growing as the digital revolution keeps progressing. NEU will take part as the interconnected sufferers and caters keep abreast of our progress. It won’t take years to boost sales. We’ve got Orphan Status.

Only 12 months to go in this long journey, however our shareprice has started its climb now.

Expand

Good to remember some of the older chit chat on valuations and how an acquisition might work

NEU Price at posting: $13.23 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BUX

Buxton projects new graphite province discovery at WA Narryer play

There are more pages in this discussion • 15 more messages in this thread...

First 205 Last

Add NEU (ASX) to my watchlist

(20min delay)
Last $14.05		Change -0.510(3.50%)		Mkt cap ! $1.795B

Open	High	Low	Value	Volume
$14.38	$14.42	$13.94	$6.419M	454.6K

Buyers (Bids)

No.	Vol.	Price($)
1	500	$13.99

Sellers (Offers)

Price($)	Vol.	No.
$14.07	6644	4

View Market Depth

No.	Vol.	Price($)
1	500	13.990
1	300	13.970
1	1432	13.950
2	1230	13.900
1	720	13.890

Price($)	Vol.	No.
14.420	175	1
14.500	2985	2
14.800	2850	2
14.860	500	1
14.960	445	1

Last trade - 16.10pm 04/10/2024 (20 minute delay)

NEU (ASX) Chart

Good to remember some of the older chit chat on valuations and...

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Buxton projects new graphite province discovery at WA Narryer play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Good to remember some of the older chit chat on valuations and...

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Buxton projects new graphite province discovery at WA Narryer play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News